All In Biotech

Drug Trial Radar · NCT02750293

The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors

The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors in Subjects With Low Serum 25-hydroxyvitamin D Levels

Last checked: Nov 19, 2026Latest source record: Oct 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 411 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

411

Actual

Start

Jun 2015

Primary completion

Aug 2017

Study completion Sep 2017

Sponsor

Lead sponsor
University of TromsoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 25, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 20 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Six-hundred subjects with vitamin D deficiency will be randomized to vitamin D 3000 IU per day versus placebo for 4 months, with effects on cardiovascular risk factors as main endpoint

Conditions

  • Vitamin D Deficiency

Interventions

  • CholecalciferolDrug

    Vitamin D preparation

  • PlaceboDrug

    placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in systolic and diastolic blood pressureTime frame: 4 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospital of North Norway

    Tromsø, Norway

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.